semaglutide dangers The Therapeutic Goods Administration has issued an urgent safety warning over the risk of suicidal thoughts linked to popular drugs used to treat type 2 diabetes and obesity. The affected drugs include Ozempic: Semaglutide is a GLP-1

Some patients may be candidates for GLP-1 medications such as semaglutide or similar treatments that help regulate appetite, improve blood sugar control, and support gradual weight loss when combined with lifestyle changes

Helpful Tools Related Articles Retatrutide Availability & Timeline Retatrutide is expected to receive FDA approval in mid-2027 with pharmacy availability in late 2027

The American Academy of Ophthalmology has said it does not support a blanket recommendation for all patients to immediately stop taking semaglutide if they develop NAION because of risks for those with difficult-to-manage diabetes or underlying vascular health conditions

Start your intake What Does Cinnamon Actually Do to GLP-1